María Celia
Miralles Alvarez
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublications in collaboration with researchers from Hospital Universitario Marqués de Valdecilla (12)
2022
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2009
-
The Spanish HIV BioBank: A model of cooperative HIV research
Retrovirology, Vol. 6
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2007
-
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
Journal of Viral Hepatitis, Vol. 14, Núm. 6, pp. 387-391
-
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin
Antiviral Therapy, Vol. 12, Núm. 4, pp. 469-476
-
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: The PRESCO trial
AIDS Research and Human Retroviruses, Vol. 23, Núm. 8, pp. 972-982
2005
-
Impact of ribavirin exposure on early virological response to hepatitis C therapy in HIV-infected patients with chronic hepatitis C
Antiviral Therapy, Vol. 10, Núm. 5, pp. 657-662
-
Recommendations from GESIDA/SEFH/PNS to improve adherence to antiviral treatment (2004)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 4, pp. 221-231
2004
2000
1999
-
A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients
AIDS, Vol. 13, Núm. 13, pp. 1727-1735